Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Blockade in Minimally Invasive Mitral Valve Replacement
NCT03415555Phase 4Completed
- Sponsor
- Medical University of Lublin
- Start
- Feb 2018
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by Medical University of Lublin. Started Feb 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03415555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415555.